We host world-class facilities, laboratories, research equipment and our state-of-the-art clinical trial centre unlocking new frontiers of discovery and innovation.

Our facilities and specialised support offer specialised expertise and support in flow cytometry, laboratory operations, the Sequenom platform, shipping logistics, and tissue culture.

Biobanking Facility

Supporting Melbourne Children’s campus research involving biospecimens by providing advice and support through study planning, grant application justification and costing, and ethics approval.

Read about Biobanking

Clinical Epidemiology & Biostatistics Unit (CEBU)

Provides researchers with high-level expertise in biostatistics, epidemiological methods and data management to ensure the conduct of high-quality studies.

Read about CEBU

 

Flow Cytometry and Imaging Facility

Provides researchers with high-performance instrumentation and comprehensive support for performing flow cytometric analysis, cell sorting (FACS), and confocal and wide-field microscopy.

Read about imaging facilities

Research MRI scanner

The Melbourne Children’s Campus has a Siemens Prisma 3T MRI scanner and Mock Scanner facilities available for bookings by approved research projects.

Make a booking

 

Tissue Culture

Provides cell cultures and media for research scientists and establishes skin fibroblast or lymphoblast cultures from patients for diagnostic and quality assurance testing.

Read about Tissue Culture

 

Clinical trials support

We also have a state-of-the-art Melbourne Children's Trials Centre (MCTC) that provides support for clinical trials.

Melbourne Children's Trials Centre

MCTC provides support for clinical trials, ranging from trials of novel therapies to large preventative public health trials. Clinical trials are essential to explore the effectiveness of promising new therapies and to determine how existing treatments can be used most effectively.

Read about MCTC

 

 

Stem cell core facilities

MCRI's Stem Cell Core operates fee-for-service to provide researchers with customised iPSC derivation and genome editing based on the latest cutting-edge stem cell technologies. 

Services are available for both internal and external clients.

iPS Derivation & Gene Editing Facility

This facility brings together a team of highly experienced stem cell and molecular biologists with over 40 years of combined experience to generate standard and gene-edited iPSC lines in feeder-free and chemically defined medium in a manner that is both rapid and cost-effective.

Read about iPS & Gene Editing

Stafford Fox Drug Discovery Facility

This facility at MCRI offers an automated platform for high throughput/high content drug screening of patient’s induced Pluripotent Stem Cell (iPSC) derived tissues.

Read about our Drug Discovery Facility